NEKTAR THERAPEUTICS NKTR
CIK 0000906709
Form 4 transactions dated Oct 1, 2023 to Oct 15, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $3.96M
Oct 1, 2023 – Sep 25, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| Aug 18, 2026 | Zalevsky Jonathan Chief R&D Officer | Sale | $13.39K 186 shares sold | 1.91% sold Direct holding | ▾ |
| Aug 18, 2026 | ROBIN HOWARD W President & CEO · Director | Sale | $30.09K 418 shares sold | 0.76% sold Direct holding | ▾ |
| Jun 30, 2026 | Zalevsky Jonathan Chief R&D Officer | Sale10b5-1 footnote | $397.67K 5,681 shares sold | 36.80% sold Direct holding | ▾ |
| Jun 17, 2026 | ROBIN HOWARD W President & CEO · Director | Sale10b5-1 footnote | $611.88K 10,000 shares sold | 15.37% sold Direct holding | ▾ |
| Jun 16, 2026 | ROBIN HOWARD W President & CEO · Director | Sale10b5-1 footnote | $603.18K 10,000 shares sold | 13.33% sold Direct holding | ▾ |
| Jun 15, 2026 | Zalevsky Jonathan Chief R&D Officer | Sale10b5-1 footnote | $336.21K 5,538 shares sold | 26.40% sold Direct holding | ▾ |
| May 19, 2026 | Zalevsky Jonathan Chief R&D Officer | Sale | $13.04K 199 shares sold | 0.94% sold Direct holding | ▾ |
| May 19, 2026 | ROBIN HOWARD W President & CEO · Director | Sale | $29.09K 444 shares sold | 0.59% sold Direct holding | ▾ |
| Feb 18, 2026 | Zalevsky Jonathan Chief R&D Officer | Sale | $13.14K 180 shares sold | 0.84% sold Direct holding | ▾ |
| Feb 18, 2026 | ROBIN HOWARD W President & CEO · Director | Sale | $30.88K 423 shares sold | 0.56% sold Direct holding | ▾ |
Showing 11 / 11 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 11 of 11 purchase / sale groups and 12 of 12 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"NKTR","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.